Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 77 | 2013 | 1026 | 3.450 |
Why?
|
Heart Failure | 42 | 2014 | 2128 | 1.700 |
Why?
|
Heart Transplantation | 43 | 2014 | 854 | 1.570 |
Why?
|
Assisted Circulation | 14 | 2012 | 34 | 1.290 |
Why?
|
Mast Cells | 7 | 2008 | 74 | 1.060 |
Why?
|
Heart, Artificial | 17 | 2008 | 69 | 0.820 |
Why?
|
Myocardium | 19 | 2011 | 986 | 0.660 |
Why?
|
Hemodynamics | 25 | 2013 | 845 | 0.610 |
Why?
|
Graft Rejection | 15 | 2014 | 582 | 0.600 |
Why?
|
Equipment Design | 29 | 2005 | 604 | 0.580 |
Why?
|
Tissue Donors | 9 | 2014 | 496 | 0.560 |
Why?
|
Cardiac Output, Low | 5 | 2008 | 66 | 0.530 |
Why?
|
Coronary Artery Bypass | 12 | 2009 | 489 | 0.500 |
Why?
|
Ventricular Remodeling | 7 | 2007 | 174 | 0.470 |
Why?
|
Cardiac Surgical Procedures | 10 | 2011 | 1099 | 0.430 |
Why?
|
Societies, Scientific | 1 | 2012 | 26 | 0.410 |
Why?
|
Artificial Organs | 1 | 2012 | 13 | 0.410 |
Why?
|
Transplant Recipients | 1 | 2014 | 209 | 0.400 |
Why?
|
Middle Aged | 103 | 2014 | 26012 | 0.380 |
Why?
|
Cardiopulmonary Bypass | 15 | 1997 | 343 | 0.370 |
Why?
|
Humans | 198 | 2014 | 123133 | 0.360 |
Why?
|
Transplantation, Heterotopic | 5 | 2014 | 29 | 0.360 |
Why?
|
Ventricular Function, Right | 3 | 2004 | 112 | 0.350 |
Why?
|
Organ Transplantation | 2 | 2008 | 162 | 0.340 |
Why?
|
Postoperative Complications | 29 | 2008 | 3017 | 0.340 |
Why?
|
Periodicals as Topic | 1 | 2012 | 195 | 0.330 |
Why?
|
Hemolysis | 18 | 2004 | 105 | 0.330 |
Why?
|
History, 20th Century | 5 | 2012 | 381 | 0.310 |
Why?
|
Coronary Occlusion | 1 | 2009 | 27 | 0.310 |
Why?
|
Ventricular Function, Left | 10 | 2005 | 497 | 0.310 |
Why?
|
Adult | 91 | 2014 | 29024 | 0.310 |
Why?
|
Thrombosis | 13 | 2007 | 520 | 0.300 |
Why?
|
Models, Cardiovascular | 11 | 2013 | 180 | 0.280 |
Why?
|
Cathepsins | 1 | 2007 | 21 | 0.280 |
Why?
|
Hypertension, Pulmonary | 2 | 2009 | 434 | 0.280 |
Why?
|
Male | 112 | 2014 | 60117 | 0.280 |
Why?
|
General Surgery | 1 | 2008 | 203 | 0.270 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2005 | 665 | 0.270 |
Why?
|
Equipment Safety | 3 | 2005 | 37 | 0.270 |
Why?
|
Serine Endopeptidases | 1 | 2007 | 175 | 0.260 |
Why?
|
Cardiomyopathy, Dilated | 8 | 2006 | 214 | 0.260 |
Why?
|
Lung Transplantation | 15 | 1997 | 316 | 0.260 |
Why?
|
Female | 107 | 2014 | 65560 | 0.250 |
Why?
|
Heart Ventricles | 12 | 2006 | 762 | 0.250 |
Why?
|
History, 21st Century | 3 | 2012 | 269 | 0.240 |
Why?
|
Cardiomyopathies | 5 | 2006 | 478 | 0.230 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2005 | 121 | 0.230 |
Why?
|
Patient Selection | 3 | 2003 | 684 | 0.230 |
Why?
|
Aged | 54 | 2012 | 19110 | 0.220 |
Why?
|
Bioprosthesis | 2 | 2004 | 111 | 0.220 |
Why?
|
Shock, Cardiogenic | 3 | 2008 | 187 | 0.210 |
Why?
|
Cardiology | 1 | 2008 | 473 | 0.210 |
Why?
|
Polytetrafluoroethylene | 5 | 2008 | 80 | 0.210 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2004 | 85 | 0.210 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2008 | 429 | 0.210 |
Why?
|
Aorta | 6 | 2013 | 542 | 0.210 |
Why?
|
Heart Valve Prosthesis | 6 | 2004 | 293 | 0.210 |
Why?
|
Biliopancreatic Diversion | 1 | 2002 | 4 | 0.200 |
Why?
|
Foreign Bodies | 1 | 2003 | 104 | 0.200 |
Why?
|
Blood Vessel Prosthesis | 14 | 2008 | 533 | 0.200 |
Why?
|
Pulsatile Flow | 10 | 2014 | 133 | 0.200 |
Why?
|
Postoperative Care | 7 | 2001 | 295 | 0.190 |
Why?
|
Prosthesis Design | 14 | 2010 | 672 | 0.190 |
Why?
|
Tissue Engineering | 2 | 2014 | 176 | 0.190 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2001 | 67 | 0.180 |
Why?
|
Monitoring, Physiologic | 8 | 2000 | 361 | 0.180 |
Why?
|
Heart | 8 | 1999 | 723 | 0.180 |
Why?
|
Carotid Arteries | 5 | 2011 | 151 | 0.180 |
Why?
|
Survival Rate | 7 | 2014 | 2000 | 0.180 |
Why?
|
Obesity, Morbid | 1 | 2002 | 184 | 0.170 |
Why?
|
Aortic Valve Stenosis | 1 | 2004 | 332 | 0.170 |
Why?
|
Myocytes, Cardiac | 5 | 2011 | 618 | 0.160 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2001 | 258 | 0.160 |
Why?
|
Heart-Lung Transplantation | 6 | 2006 | 23 | 0.160 |
Why?
|
Cattle | 21 | 2001 | 558 | 0.160 |
Why?
|
Biocompatible Materials | 7 | 1999 | 123 | 0.150 |
Why?
|
Blood Flow Velocity | 12 | 2012 | 450 | 0.150 |
Why?
|
Prosthesis Implantation | 6 | 2008 | 143 | 0.140 |
Why?
|
Ventricular Function | 3 | 2010 | 92 | 0.140 |
Why?
|
Collagen | 6 | 2006 | 317 | 0.130 |
Why?
|
Anticoagulants | 1 | 2001 | 581 | 0.130 |
Why?
|
Coronary Disease | 9 | 1999 | 637 | 0.130 |
Why?
|
Aortic Aneurysm | 5 | 2012 | 224 | 0.130 |
Why?
|
Hydrodynamics | 2 | 2013 | 16 | 0.130 |
Why?
|
Hemostasis, Surgical | 2 | 2001 | 37 | 0.130 |
Why?
|
Treatment Outcome | 11 | 2011 | 12129 | 0.130 |
Why?
|
Hyperparathyroidism | 2 | 1987 | 24 | 0.130 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 936 | 0.130 |
Why?
|
Parathyroid Glands | 2 | 1987 | 28 | 0.130 |
Why?
|
Blood Pressure | 8 | 2005 | 1325 | 0.130 |
Why?
|
Contrast Media | 2 | 2011 | 470 | 0.120 |
Why?
|
Ultrasonography | 2 | 1990 | 940 | 0.120 |
Why?
|
Femoral Artery | 8 | 2008 | 190 | 0.120 |
Why?
|
Dystrophin | 3 | 2004 | 37 | 0.120 |
Why?
|
Leg | 4 | 2012 | 155 | 0.120 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 1986 | 94 | 0.120 |
Why?
|
Cholecystectomy | 2 | 1993 | 56 | 0.120 |
Why?
|
Pericardium | 2 | 2014 | 82 | 0.120 |
Why?
|
Animals | 42 | 2014 | 33803 | 0.120 |
Why?
|
Heart Valves | 1 | 2014 | 51 | 0.120 |
Why?
|
Stroke Volume | 6 | 2004 | 445 | 0.110 |
Why?
|
Risk Factors | 9 | 2014 | 10017 | 0.110 |
Why?
|
Multiple Organ Failure | 2 | 2008 | 140 | 0.110 |
Why?
|
Oxygen | 7 | 2012 | 550 | 0.110 |
Why?
|
United States | 9 | 2014 | 10652 | 0.110 |
Why?
|
Sex Distribution | 1 | 2014 | 294 | 0.110 |
Why?
|
Age Distribution | 1 | 2014 | 409 | 0.110 |
Why?
|
Transplantation, Homologous | 9 | 2008 | 659 | 0.110 |
Why?
|
Dogs | 12 | 1992 | 765 | 0.100 |
Why?
|
Heart Diseases | 3 | 2007 | 482 | 0.100 |
Why?
|
Cell Phone | 1 | 2012 | 29 | 0.100 |
Why?
|
Organ Preservation | 2 | 1991 | 36 | 0.100 |
Why?
|
Time Factors | 20 | 2006 | 6223 | 0.100 |
Why?
|
Aneurysm | 4 | 1984 | 88 | 0.100 |
Why?
|
Disease-Free Survival | 1 | 2014 | 859 | 0.100 |
Why?
|
Myocardial Ischemia | 4 | 2004 | 332 | 0.100 |
Why?
|
Hyperemia | 1 | 2012 | 25 | 0.100 |
Why?
|
Cardiomegaly | 2 | 2004 | 133 | 0.100 |
Why?
|
Vasa Vasorum | 1 | 2011 | 3 | 0.100 |
Why?
|
Carotid Artery Diseases | 2 | 2011 | 147 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 169 | 0.090 |
Why?
|
Muscular Diseases | 1 | 2012 | 102 | 0.090 |
Why?
|
Carotid Intima-Media Thickness | 1 | 2011 | 72 | 0.090 |
Why?
|
Microvessels | 1 | 2011 | 56 | 0.090 |
Why?
|
Heart-Lung Machine | 6 | 2004 | 7 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2012 | 216 | 0.090 |
Why?
|
Intra-Aortic Balloon Pumping | 3 | 2003 | 42 | 0.090 |
Why?
|
Comorbidity | 2 | 2014 | 1496 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 220 | 0.090 |
Why?
|
Adolescent | 26 | 2014 | 19104 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 3545 | 0.090 |
Why?
|
Embolism | 5 | 2001 | 48 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 240 | 0.090 |
Why?
|
Plateletpheresis | 1 | 1990 | 2 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 119 | 0.090 |
Why?
|
Preoperative Care | 3 | 1999 | 350 | 0.090 |
Why?
|
Catheterization | 5 | 2001 | 235 | 0.090 |
Why?
|
Plasmapheresis | 1 | 1990 | 29 | 0.090 |
Why?
|
Prosthesis Failure | 2 | 2006 | 159 | 0.080 |
Why?
|
Follow-Up Studies | 15 | 2005 | 5050 | 0.080 |
Why?
|
Radionuclide Angiography | 1 | 1989 | 3 | 0.080 |
Why?
|
Blood Component Removal | 1 | 1990 | 32 | 0.080 |
Why?
|
Lung | 12 | 2005 | 1463 | 0.080 |
Why?
|
Kidney Failure, Chronic | 4 | 1986 | 864 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 238 | 0.080 |
Why?
|
Transplantation Immunology | 2 | 2008 | 53 | 0.080 |
Why?
|
Materials Testing | 1 | 1989 | 73 | 0.080 |
Why?
|
Urine | 1 | 1989 | 88 | 0.080 |
Why?
|
Tissue and Organ Procurement | 2 | 1991 | 218 | 0.080 |
Why?
|
Immunosuppressive Agents | 4 | 2008 | 642 | 0.080 |
Why?
|
Medical Illustration | 1 | 2008 | 18 | 0.080 |
Why?
|
International Cooperation | 1 | 2009 | 157 | 0.080 |
Why?
|
Ischemia | 1 | 2012 | 344 | 0.080 |
Why?
|
Awards and Prizes | 1 | 2009 | 63 | 0.080 |
Why?
|
Stem Cell Factor | 1 | 2008 | 13 | 0.080 |
Why?
|
Reoperation | 4 | 2004 | 819 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2008 | 53 | 0.080 |
Why?
|
Thromboembolism | 5 | 2008 | 84 | 0.070 |
Why?
|
Acute Disease | 3 | 2008 | 1093 | 0.070 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 1987 | 12 | 0.070 |
Why?
|
Parathyroid Hormone | 2 | 1987 | 72 | 0.070 |
Why?
|
Cathepsin G | 1 | 2007 | 3 | 0.070 |
Why?
|
Chymases | 1 | 2007 | 6 | 0.070 |
Why?
|
Retrospective Studies | 12 | 2009 | 16050 | 0.070 |
Why?
|
Coronary Vessels | 2 | 1991 | 526 | 0.070 |
Why?
|
Pleural Effusion | 1 | 2008 | 101 | 0.070 |
Why?
|
Tryptases | 1 | 2007 | 20 | 0.070 |
Why?
|
Endomyocardial Fibrosis | 1 | 2006 | 3 | 0.070 |
Why?
|
Intraoperative Care | 2 | 2001 | 103 | 0.070 |
Why?
|
In Vitro Techniques | 12 | 1997 | 966 | 0.070 |
Why?
|
Renal Dialysis | 4 | 1987 | 842 | 0.070 |
Why?
|
Equipment Failure | 2 | 2005 | 122 | 0.070 |
Why?
|
Cardiac Output | 11 | 2005 | 169 | 0.070 |
Why?
|
Receptors, Interleukin-2 | 3 | 1991 | 43 | 0.070 |
Why?
|
Incidence | 1 | 2014 | 3044 | 0.070 |
Why?
|
Necrosis | 1 | 2007 | 205 | 0.070 |
Why?
|
Proteoglycans | 1 | 2006 | 92 | 0.070 |
Why?
|
Median Nerve | 1 | 1986 | 15 | 0.070 |
Why?
|
Nerve Compression Syndromes | 1 | 1986 | 20 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 1999 | 621 | 0.070 |
Why?
|
Complement Membrane Attack Complex | 1 | 2006 | 7 | 0.070 |
Why?
|
Angiotensin II | 1 | 2007 | 161 | 0.070 |
Why?
|
Splenic Rupture | 1 | 2006 | 5 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2006 | 147 | 0.070 |
Why?
|
Early Ambulation | 1 | 2006 | 8 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 2 | 2005 | 238 | 0.060 |
Why?
|
Endothelium | 1 | 1986 | 72 | 0.060 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2006 | 56 | 0.060 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2006 | 57 | 0.060 |
Why?
|
Rheology | 5 | 1994 | 31 | 0.060 |
Why?
|
Albumins | 1 | 2006 | 88 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2008 | 3239 | 0.060 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2006 | 443 | 0.060 |
Why?
|
Hemoglobins | 8 | 1997 | 301 | 0.060 |
Why?
|
Fluorocarbons | 1 | 2006 | 56 | 0.060 |
Why?
|
Societies, Medical | 1 | 2009 | 676 | 0.060 |
Why?
|
Dextrocardia | 1 | 2005 | 9 | 0.060 |
Why?
|
Algorithms | 1 | 2012 | 1596 | 0.060 |
Why?
|
Thrombolytic Therapy | 1 | 2007 | 204 | 0.060 |
Why?
|
Mitral Valve | 5 | 2003 | 246 | 0.060 |
Why?
|
Popliteal Vein | 1 | 1984 | 9 | 0.060 |
Why?
|
Endothelin-1 | 1 | 2005 | 39 | 0.060 |
Why?
|
Antibody Formation | 1 | 2005 | 256 | 0.060 |
Why?
|
Gastroparesis | 1 | 2006 | 66 | 0.060 |
Why?
|
Centrifugation | 5 | 1997 | 25 | 0.060 |
Why?
|
Epoprostenol | 1 | 2005 | 67 | 0.060 |
Why?
|
Simvastatin | 1 | 2005 | 75 | 0.060 |
Why?
|
Triglycerides | 3 | 2004 | 561 | 0.060 |
Why?
|
Pulmonary Artery | 3 | 2001 | 439 | 0.060 |
Why?
|
Quality of Life | 3 | 2005 | 1929 | 0.060 |
Why?
|
Brain Death | 1 | 2005 | 56 | 0.060 |
Why?
|
Chronic Disease | 2 | 2008 | 1163 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2004 | 54 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2005 | 117 | 0.060 |
Why?
|
Fibrosis | 5 | 2005 | 429 | 0.060 |
Why?
|
Intraoperative Complications | 3 | 1996 | 175 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 534 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 455 | 0.060 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2001 | 109 | 0.060 |
Why?
|
Disease Progression | 2 | 2007 | 2028 | 0.060 |
Why?
|
Cardiomyoplasty | 1 | 2003 | 6 | 0.050 |
Why?
|
Blood Coagulation | 3 | 2001 | 120 | 0.050 |
Why?
|
Aortography | 6 | 2013 | 200 | 0.050 |
Why?
|
Fibroblasts | 2 | 2006 | 880 | 0.050 |
Why?
|
Cell Communication | 1 | 2004 | 165 | 0.050 |
Why?
|
Biopsy | 7 | 2006 | 1238 | 0.050 |
Why?
|
Bronchiolitis Obliterans | 2 | 1995 | 39 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2004 | 71 | 0.050 |
Why?
|
Extracorporeal Circulation | 8 | 1976 | 53 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2006 | 458 | 0.050 |
Why?
|
Perioperative Care | 1 | 2005 | 195 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2003 | 100 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2003 | 96 | 0.050 |
Why?
|
Blood Coagulation Disorders | 1 | 2003 | 100 | 0.050 |
Why?
|
Intraoperative Period | 3 | 1991 | 73 | 0.050 |
Why?
|
Exercise Test | 2 | 2000 | 249 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2005 | 755 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 398 | 0.050 |
Why?
|
Angiography | 6 | 1987 | 215 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2001 | 30 | 0.050 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2001 | 29 | 0.050 |
Why?
|
S100 Proteins | 1 | 2001 | 45 | 0.050 |
Why?
|
Coronary Angiography | 3 | 1999 | 420 | 0.050 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 72 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2006 | 6376 | 0.050 |
Why?
|
Premedication | 1 | 2001 | 43 | 0.050 |
Why?
|
Postoperative Period | 3 | 2000 | 330 | 0.050 |
Why?
|
Waiting Lists | 2 | 2000 | 225 | 0.050 |
Why?
|
Cause of Death | 2 | 1996 | 463 | 0.050 |
Why?
|
Infant | 5 | 2014 | 12365 | 0.050 |
Why?
|
Child, Preschool | 8 | 2014 | 13900 | 0.050 |
Why?
|
Evaluation Studies as Topic | 7 | 1996 | 258 | 0.050 |
Why?
|
Microcomputers | 1 | 2001 | 10 | 0.050 |
Why?
|
Complement Activation | 1 | 2001 | 52 | 0.050 |
Why?
|
Oximetry | 2 | 1992 | 160 | 0.050 |
Why?
|
Cell Count | 3 | 2005 | 250 | 0.040 |
Why?
|
Blood Coagulation Factors | 1 | 2000 | 34 | 0.040 |
Why?
|
Predictive Value of Tests | 5 | 2011 | 2111 | 0.040 |
Why?
|
Young Adult | 1 | 2014 | 8839 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2001 | 327 | 0.040 |
Why?
|
Child | 13 | 2014 | 24240 | 0.040 |
Why?
|
Hernia, Diaphragmatic, Traumatic | 3 | 1988 | 9 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2001 | 233 | 0.040 |
Why?
|
Arteriosclerosis | 3 | 1989 | 137 | 0.040 |
Why?
|
Graft Survival | 2 | 1994 | 525 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1999 | 99 | 0.040 |
Why?
|
Posture | 1 | 2000 | 152 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2001 | 151 | 0.040 |
Why?
|
Intermittent Claudication | 3 | 1989 | 55 | 0.040 |
Why?
|
Palliative Care | 2 | 2000 | 428 | 0.040 |
Why?
|
Models, Structural | 3 | 1993 | 49 | 0.040 |
Why?
|
Death, Sudden, Cardiac | 2 | 1991 | 248 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2006 | 2850 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2014 | 3042 | 0.040 |
Why?
|
Subclavian Artery | 5 | 1979 | 71 | 0.040 |
Why?
|
Cytokines | 1 | 2005 | 1284 | 0.040 |
Why?
|
Radiography | 5 | 2008 | 822 | 0.040 |
Why?
|
Cell Size | 3 | 2004 | 81 | 0.040 |
Why?
|
Prognosis | 8 | 2011 | 4513 | 0.040 |
Why?
|
Opportunistic Infections | 2 | 1989 | 78 | 0.040 |
Why?
|
Swine | 3 | 2014 | 1155 | 0.040 |
Why?
|
Mediastinum | 2 | 1991 | 41 | 0.040 |
Why?
|
Femoral Vein | 2 | 1991 | 50 | 0.040 |
Why?
|
Myocardial Contraction | 1 | 1999 | 260 | 0.040 |
Why?
|
Pulmonary Edema | 2 | 1997 | 49 | 0.040 |
Why?
|
Kidney | 1 | 2005 | 1335 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 2055 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 715 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2000 | 404 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2006 | 796 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2008 | 1688 | 0.040 |
Why?
|
Arteriovenous Anastomosis | 2 | 1987 | 5 | 0.040 |
Why?
|
Aprotinin | 1 | 1996 | 11 | 0.030 |
Why?
|
Veins | 2 | 1984 | 106 | 0.030 |
Why?
|
Transplantation, Autologous | 3 | 1986 | 297 | 0.030 |
Why?
|
Cohort Studies | 3 | 2008 | 4706 | 0.030 |
Why?
|
Hemostatics | 1 | 1996 | 58 | 0.030 |
Why?
|
Inflammation | 1 | 2003 | 1403 | 0.030 |
Why?
|
Lung Diseases | 4 | 1995 | 378 | 0.030 |
Why?
|
Cardiac Catheterization | 4 | 2005 | 631 | 0.030 |
Why?
|
Platelet Aggregation | 3 | 1986 | 120 | 0.030 |
Why?
|
Aorta, Thoracic | 3 | 1979 | 520 | 0.030 |
Why?
|
Prostheses and Implants | 2 | 1995 | 150 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2014 | 1909 | 0.030 |
Why?
|
Blood Pressure Monitors | 1 | 1995 | 3 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1986 | 153 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 2 | 1991 | 61 | 0.030 |
Why?
|
Magnetic Fields | 1 | 2014 | 7 | 0.030 |
Why?
|
Bioreactors | 1 | 2014 | 38 | 0.030 |
Why?
|
Risk Assessment | 1 | 2004 | 3317 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 1995 | 105 | 0.030 |
Why?
|
Radionuclide Imaging | 4 | 1991 | 151 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 1997 | 257 | 0.030 |
Why?
|
Models, Theoretical | 2 | 1994 | 356 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2006 | 537 | 0.030 |
Why?
|
Renal Artery | 2 | 1977 | 74 | 0.030 |
Why?
|
Polyurethanes | 5 | 1995 | 18 | 0.030 |
Why?
|
Hyperplasia | 2 | 1985 | 210 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2014 | 328 | 0.030 |
Why?
|
Fetal Blood | 1 | 2014 | 177 | 0.030 |
Why?
|
Subclavian Vein | 2 | 1972 | 23 | 0.030 |
Why?
|
Forecasting | 3 | 2004 | 354 | 0.030 |
Why?
|
Computer Simulation | 2 | 2012 | 630 | 0.030 |
Why?
|
Cyclosporine | 1 | 1993 | 146 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2005 | 355 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 2014 | 0.030 |
Why?
|
Prospective Studies | 5 | 2006 | 6030 | 0.030 |
Why?
|
Heart Arrest, Induced | 2 | 1991 | 73 | 0.030 |
Why?
|
Popliteal Artery | 2 | 1989 | 53 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2012 | 2828 | 0.030 |
Why?
|
Systems Integration | 1 | 2012 | 27 | 0.030 |
Why?
|
Oxygenators | 2 | 1991 | 3 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 1993 | 148 | 0.030 |
Why?
|
Echocardiography | 3 | 2005 | 1049 | 0.030 |
Why?
|
United States National Aeronautics and Space Administration | 3 | 1997 | 19 | 0.020 |
Why?
|
Diagnosis, Differential | 4 | 1986 | 1876 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2014 | 803 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1992 | 120 | 0.020 |
Why?
|
Survival Analysis | 3 | 2005 | 1473 | 0.020 |
Why?
|
Echo-Planar Imaging | 1 | 2012 | 20 | 0.020 |
Why?
|
Heart Function Tests | 2 | 1991 | 56 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 1993 | 147 | 0.020 |
Why?
|
Blotting, Western | 2 | 2006 | 1100 | 0.020 |
Why?
|
Gene Expression | 2 | 2008 | 1565 | 0.020 |
Why?
|
Aorta, Abdominal | 5 | 1980 | 120 | 0.020 |
Why?
|
Anesthesia | 2 | 1993 | 212 | 0.020 |
Why?
|
Subclavian Steal Syndrome | 1 | 1991 | 7 | 0.020 |
Why?
|
Bradycardia | 1 | 1991 | 59 | 0.020 |
Why?
|
Cholelithiasis | 1 | 1991 | 17 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 3 | 1991 | 459 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 1995 | 1309 | 0.020 |
Why?
|
Creatinine | 4 | 1996 | 380 | 0.020 |
Why?
|
Gated Blood-Pool Imaging | 1 | 1991 | 3 | 0.020 |
Why?
|
Angina Pectoris | 1 | 1991 | 57 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 2 | 1996 | 61 | 0.020 |
Why?
|
Blood Urea Nitrogen | 3 | 1996 | 70 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2005 | 393 | 0.020 |
Why?
|
Image Enhancement | 1 | 2012 | 166 | 0.020 |
Why?
|
Polyethylene Terephthalates | 5 | 2005 | 40 | 0.020 |
Why?
|
Total Lung Capacity | 1 | 1990 | 12 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 1990 | 213 | 0.020 |
Why?
|
Recurrence | 3 | 2007 | 1419 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 1990 | 38 | 0.020 |
Why?
|
Pulmonary Ventilation | 1 | 1990 | 28 | 0.020 |
Why?
|
Tissue Scaffolds | 1 | 2011 | 74 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 1991 | 117 | 0.020 |
Why?
|
Hydrocortisone | 1 | 1991 | 215 | 0.020 |
Why?
|
Calcium | 2 | 1987 | 1096 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1992 | 269 | 0.020 |
Why?
|
DNA, Viral | 1 | 1992 | 479 | 0.020 |
Why?
|
Hypertension | 2 | 2001 | 1286 | 0.020 |
Why?
|
Hemorrhage | 2 | 2005 | 458 | 0.020 |
Why?
|
Platelet Function Tests | 1 | 1990 | 38 | 0.020 |
Why?
|
Oxygenators, Membrane | 5 | 1976 | 8 | 0.020 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 1989 | 2 | 0.020 |
Why?
|
Urodynamics | 1 | 1989 | 39 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2006 | 2809 | 0.020 |
Why?
|
Endarterectomy | 1 | 1989 | 22 | 0.020 |
Why?
|
Regeneration | 1 | 2011 | 201 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 1990 | 117 | 0.020 |
Why?
|
Surgical Instruments | 1 | 1989 | 56 | 0.020 |
Why?
|
Myocardial Infarction | 4 | 1996 | 1001 | 0.020 |
Why?
|
Biomarkers | 3 | 2006 | 2944 | 0.020 |
Why?
|
Graft Occlusion, Vascular | 2 | 1986 | 95 | 0.020 |
Why?
|
Technology Assessment, Biomedical | 1 | 1988 | 32 | 0.020 |
Why?
|
Systole | 3 | 2001 | 196 | 0.020 |
Why?
|
Prevalence | 2 | 2008 | 2404 | 0.020 |
Why?
|
Exudates and Transudates | 1 | 2008 | 22 | 0.020 |
Why?
|
Esophageal Perforation | 1 | 1968 | 15 | 0.020 |
Why?
|
Paracentesis | 1 | 2008 | 17 | 0.020 |
Why?
|
Bacteriuria | 1 | 1989 | 82 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 1988 | 139 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2005 | 50 | 0.020 |
Why?
|
Diaphragm | 1 | 1988 | 99 | 0.020 |
Why?
|
Hypoparathyroidism | 1 | 1987 | 11 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2008 | 473 | 0.020 |
Why?
|
Naphthalenes | 1 | 1987 | 37 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2006 | 1584 | 0.020 |
Why?
|
Decorin | 1 | 2006 | 7 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2001 | 1008 | 0.020 |
Why?
|
Platelet Adhesiveness | 3 | 1975 | 40 | 0.020 |
Why?
|
Texas | 3 | 1991 | 3563 | 0.020 |
Why?
|
Ulnar Nerve | 1 | 1986 | 13 | 0.020 |
Why?
|
Hematocrit | 3 | 1995 | 110 | 0.020 |
Why?
|
Carpal Tunnel Syndrome | 1 | 1986 | 19 | 0.020 |
Why?
|
Thoracic Injuries | 4 | 1979 | 91 | 0.020 |
Why?
|
Hemothorax | 2 | 2005 | 22 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 1986 | 29 | 0.020 |
Why?
|
Remission Induction | 1 | 2007 | 300 | 0.020 |
Why?
|
Heart Valve Diseases | 2 | 1986 | 166 | 0.020 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2006 | 9 | 0.020 |
Why?
|
Emergencies | 2 | 1986 | 174 | 0.020 |
Why?
|
Vascular Resistance | 2 | 1985 | 189 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 1987 | 173 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2006 | 50 | 0.020 |
Why?
|
Pilot Projects | 1 | 1990 | 1390 | 0.020 |
Why?
|
Gastric Emptying | 1 | 2006 | 78 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 330 | 0.020 |
Why?
|
Pneumonia | 1 | 1989 | 325 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 1290 | 0.020 |
Why?
|
Blood Viscosity | 1 | 1985 | 13 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 1986 | 129 | 0.020 |
Why?
|
Renal Artery Obstruction | 2 | 1977 | 41 | 0.020 |
Why?
|
Methods | 6 | 1982 | 147 | 0.020 |
Why?
|
Sarcomeres | 1 | 2004 | 30 | 0.010 |
Why?
|
Biomedical Engineering | 2 | 1992 | 30 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2005 | 90 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 2005 | 38 | 0.010 |
Why?
|
Rats, Zucker | 1 | 2004 | 41 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 1987 | 230 | 0.010 |
Why?
|
Elasticity | 1 | 1985 | 92 | 0.010 |
Why?
|
Myosins | 1 | 2004 | 46 | 0.010 |
Why?
|
Hypertrophy | 1 | 2005 | 100 | 0.010 |
Why?
|
Carbon Dioxide | 5 | 1997 | 273 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2005 | 133 | 0.010 |
Why?
|
HSP47 Heat-Shock Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2005 | 143 | 0.010 |
Why?
|
Extracellular Space | 1 | 2004 | 89 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 2307 | 0.010 |
Why?
|
Organ Specificity | 1 | 2005 | 423 | 0.010 |
Why?
|
Perfusion | 1 | 1985 | 198 | 0.010 |
Why?
|
Forearm | 1 | 1983 | 44 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1983 | 96 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2004 | 233 | 0.010 |
Why?
|
Recovery of Function | 1 | 2006 | 437 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 231 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1984 | 155 | 0.010 |
Why?
|
Sepsis | 1 | 2008 | 477 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 2004 | 194 | 0.010 |
Why?
|
Turkey | 1 | 2003 | 58 | 0.010 |
Why?
|
Sex Factors | 1 | 1986 | 1262 | 0.010 |
Why?
|
Particle Size | 4 | 1975 | 115 | 0.010 |
Why?
|
Pneumonia, Viral | 3 | 1992 | 375 | 0.010 |
Why?
|
Anthropometry | 2 | 1994 | 197 | 0.010 |
Why?
|
S100 Calcium Binding Protein beta Subunit | 1 | 2001 | 16 | 0.010 |
Why?
|
Hematologic Tests | 1 | 1982 | 34 | 0.010 |
Why?
|
Leukocyte Elastase | 1 | 2001 | 19 | 0.010 |
Why?
|
Complement C3a | 1 | 2001 | 19 | 0.010 |
Why?
|
Complement C5a | 1 | 2001 | 23 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1986 | 552 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 1238 | 0.010 |
Why?
|
Critical Illness | 1 | 2006 | 591 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 1992 | 151 | 0.010 |
Why?
|
beta-Thromboglobulin | 1 | 2000 | 4 | 0.010 |
Why?
|
alpha-2-Antiplasmin | 1 | 2000 | 4 | 0.010 |
Why?
|
Platelet Factor 4 | 1 | 2000 | 22 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 2000 | 30 | 0.010 |
Why?
|
Antithrombin III | 1 | 2000 | 25 | 0.010 |
Why?
|
Respiratory Insufficiency | 2 | 1973 | 231 | 0.010 |
Why?
|
Organ Size | 1 | 2001 | 412 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 360 | 0.010 |
Why?
|
Electric Power Supplies | 2 | 1991 | 16 | 0.010 |
Why?
|
Solubility | 2 | 1991 | 132 | 0.010 |
Why?
|
Filtration | 3 | 1975 | 23 | 0.010 |
Why?
|
Antithrombins | 1 | 2000 | 56 | 0.010 |
Why?
|
Heparin | 3 | 1996 | 227 | 0.010 |
Why?
|
Wounds, Gunshot | 4 | 1970 | 139 | 0.010 |
Why?
|
Health Care Rationing | 1 | 2000 | 58 | 0.010 |
Why?
|
Thallium Radioisotopes | 1 | 1999 | 14 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2000 | 110 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2000 | 141 | 0.010 |
Why?
|
Dobutamine | 1 | 1999 | 55 | 0.010 |
Why?
|
Blood Cell Count | 2 | 1996 | 69 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 1782 | 0.010 |
Why?
|
Vimentin | 1 | 1999 | 65 | 0.010 |
Why?
|
Fibronectins | 1 | 1999 | 102 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1991 | 810 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 105 | 0.010 |
Why?
|
Age Factors | 2 | 2000 | 2804 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 1999 | 93 | 0.010 |
Why?
|
Registries | 1 | 2005 | 1395 | 0.010 |
Why?
|
Kidney Transplantation | 2 | 1975 | 630 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 1979 | 68 | 0.010 |
Why?
|
Oscillometry | 2 | 1995 | 15 | 0.010 |
Why?
|
Rats | 1 | 2004 | 3655 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 1679 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 2524 | 0.010 |
Why?
|
Cholesterol | 2 | 1993 | 525 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 1118 | 0.010 |
Why?
|
Anuria | 1 | 1977 | 13 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2000 | 434 | 0.010 |
Why?
|
Oliguria | 1 | 1977 | 19 | 0.010 |
Why?
|
Aortic Rupture | 1 | 1978 | 118 | 0.010 |
Why?
|
Diffusion | 1 | 1997 | 58 | 0.010 |
Why?
|
Liver Diseases | 1 | 2001 | 363 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2001 | 478 | 0.010 |
Why?
|
Blood Transfusion | 2 | 1996 | 304 | 0.010 |
Why?
|
Disposable Equipment | 1 | 1976 | 15 | 0.010 |
Why?
|
Quality Control | 1 | 1996 | 119 | 0.010 |
Why?
|
Platelet Count | 1 | 1996 | 133 | 0.010 |
Why?
|
Infusion Pumps, Implantable | 1 | 1996 | 40 | 0.010 |
Why?
|
Tissue Preservation | 1 | 1975 | 15 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 1996 | 147 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2000 | 420 | 0.010 |
Why?
|
Patient Care Team | 1 | 2000 | 548 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1996 | 76 | 0.010 |
Why?
|
Culture Media | 1 | 1996 | 183 | 0.010 |
Why?
|
Carbon | 2 | 1973 | 91 | 0.010 |
Why?
|
Polycarboxylate Cement | 1 | 1995 | 2 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2004 | 4287 | 0.010 |
Why?
|
Cadaver | 1 | 1975 | 129 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1996 | 150 | 0.010 |
Why?
|
Electricity | 1 | 1995 | 9 | 0.010 |
Why?
|
Oxygen Inhalation Therapy | 2 | 1992 | 91 | 0.010 |
Why?
|
Bilirubin | 1 | 1996 | 121 | 0.010 |
Why?
|
Spirometry | 1 | 1995 | 74 | 0.010 |
Why?
|
Decision Making | 1 | 2000 | 651 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1995 | 133 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 1996 | 166 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2004 | 1230 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1997 | 500 | 0.010 |
Why?
|
Models, Biological | 3 | 1987 | 1443 | 0.010 |
Why?
|
Endocardium | 1 | 1994 | 50 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 295 | 0.010 |
Why?
|
Cobalt | 1 | 1993 | 17 | 0.010 |
Why?
|
Tungsten | 1 | 1993 | 6 | 0.010 |
Why?
|
Blood Transfusion, Autologous | 1 | 1974 | 34 | 0.010 |
Why?
|
Blood Preservation | 1 | 1974 | 29 | 0.010 |
Why?
|
Aortic Valve Insufficiency | 1 | 1975 | 140 | 0.010 |
Why?
|
Giant Cells | 1 | 1993 | 34 | 0.010 |
Why?
|
Blood Chemical Analysis | 1 | 1994 | 77 | 0.010 |
Why?
|
Metals | 1 | 1993 | 61 | 0.010 |
Why?
|
Hypertension, Renal | 1 | 1973 | 37 | 0.010 |
Why?
|
Obesity | 1 | 2004 | 2230 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1973 | 27 | 0.010 |
Why?
|
Occupational Diseases | 1 | 1993 | 74 | 0.010 |
Why?
|
Hematuria | 1 | 1973 | 53 | 0.010 |
Why?
|
Double-Blind Method | 1 | 1996 | 1590 | 0.010 |
Why?
|
Oxyhemoglobins | 1 | 1992 | 22 | 0.010 |
Why?
|
Counterpulsation | 1 | 1992 | 4 | 0.010 |
Why?
|
Electronics, Medical | 1 | 1992 | 9 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 1993 | 96 | 0.010 |
Why?
|
Body Surface Area | 1 | 1992 | 31 | 0.010 |
Why?
|
Electrodes | 1 | 1992 | 97 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 1993 | 116 | 0.010 |
Why?
|
Intensive Care Units | 1 | 1996 | 483 | 0.010 |
Why?
|
Death | 1 | 1993 | 70 | 0.010 |
Why?
|
Aortic Valve | 2 | 1991 | 437 | 0.010 |
Why?
|
Cineradiography | 1 | 1991 | 3 | 0.010 |
Why?
|
HLA Antigens | 1 | 1993 | 243 | 0.010 |
Why?
|
Hematoma | 1 | 1972 | 93 | 0.010 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1991 | 13 | 0.010 |
Why?
|
Cyclosporins | 1 | 1991 | 74 | 0.010 |
Why?
|
Azathioprine | 1 | 1991 | 54 | 0.010 |
Why?
|
Software | 1 | 1996 | 674 | 0.010 |
Why?
|
Noise | 1 | 1991 | 19 | 0.010 |
Why?
|
Heart Injuries | 2 | 1968 | 46 | 0.010 |
Why?
|
Gene Amplification | 1 | 1992 | 228 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1991 | 90 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 39 | 0.010 |
Why?
|
CD4 Antigens | 1 | 1990 | 56 | 0.010 |
Why?
|
CD8 Antigens | 1 | 1990 | 41 | 0.010 |
Why?
|
Vital Capacity | 1 | 1990 | 76 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1990 | 79 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1991 | 240 | 0.010 |
Why?
|
Length of Stay | 1 | 1996 | 1289 | 0.010 |
Why?
|
Trachea | 2 | 1974 | 201 | 0.010 |
Why?
|
Heart Rate | 3 | 1981 | 586 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1972 | 223 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1977 | 614 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 1990 | 169 | 0.010 |
Why?
|
Gangrene | 1 | 1969 | 26 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 1991 | 161 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 1992 | 217 | 0.010 |
Why?
|
Bronchi | 1 | 1990 | 98 | 0.010 |
Why?
|
Drainage | 2 | 1968 | 257 | 0.010 |
Why?
|
Blood Vessels | 1 | 1970 | 104 | 0.010 |
Why?
|
Vertebral Artery | 2 | 1980 | 24 | 0.010 |
Why?
|
Electromagnetic Phenomena | 1 | 1989 | 4 | 0.010 |
Why?
|
Regression Analysis | 1 | 1991 | 767 | 0.010 |
Why?
|
Infant, Newborn | 2 | 1992 | 8111 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1991 | 684 | 0.000 |
Why?
|
Gram-Negative Bacteria | 1 | 1989 | 67 | 0.000 |
Why?
|
Pulmonary Emphysema | 1 | 1970 | 94 | 0.000 |
Why?
|
Iliac Artery | 1 | 1989 | 92 | 0.000 |
Why?
|
Pulmonary Alveoli | 1 | 1989 | 134 | 0.000 |
Why?
|
Vascular Patency | 1 | 1989 | 203 | 0.000 |
Why?
|
Influenza, Human | 1 | 1974 | 649 | 0.000 |
Why?
|
Multicenter Studies as Topic | 1 | 1989 | 261 | 0.000 |
Why?
|
Neck Injuries | 1 | 1968 | 24 | 0.000 |
Why?
|
Physical Exertion | 1 | 1988 | 81 | 0.000 |
Why?
|
Mycoses | 1 | 1989 | 116 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1991 | 1141 | 0.000 |
Why?
|
Lovastatin | 1 | 1987 | 25 | 0.000 |
Why?
|
Diastole | 1 | 1988 | 169 | 0.000 |
Why?
|
Abdominal Injuries | 1 | 1968 | 109 | 0.000 |
Why?
|
Critical Care | 1 | 1992 | 648 | 0.000 |
Why?
|
Abscess | 1 | 1968 | 138 | 0.000 |
Why?
|
Stress, Mechanical | 1 | 1987 | 170 | 0.000 |
Why?
|
Bacterial Infections | 1 | 1989 | 305 | 0.000 |
Why?
|
Accidents, Traffic | 1 | 1966 | 105 | 0.000 |
Why?
|
Radiography, Thoracic | 1 | 1966 | 152 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1991 | 1008 | 0.000 |
Why?
|
Adenosine Diphosphate | 2 | 1975 | 58 | 0.000 |
Why?
|
Laparotomy | 1 | 1966 | 135 | 0.000 |
Why?
|
Hypercholesterolemia | 1 | 1987 | 226 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1989 | 1084 | 0.000 |
Why?
|
Blood | 2 | 1976 | 105 | 0.000 |
Why?
|
Iodipamide | 1 | 1964 | 1 | 0.000 |
Why?
|
Cholangiography | 1 | 1964 | 15 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1988 | 327 | 0.000 |
Why?
|
Abdomen, Acute | 1 | 1964 | 14 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1976 | 426 | 0.000 |
Why?
|
Cholecystitis | 1 | 1964 | 20 | 0.000 |
Why?
|
Cholecystitis, Acute | 1 | 1964 | 15 | 0.000 |
Why?
|
Blood Volume Determination | 2 | 1974 | 9 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1964 | 252 | 0.000 |
Why?
|
Abdomen | 1 | 1964 | 130 | 0.000 |
Why?
|
Thrombocytopenia | 2 | 1975 | 228 | 0.000 |
Why?
|
Brachiocephalic Trunk | 2 | 1975 | 35 | 0.000 |
Why?
|
USSR | 1 | 1982 | 5 | 0.000 |
Why?
|
Hypoxia | 2 | 1974 | 248 | 0.000 |
Why?
|
Electrocardiography | 2 | 1981 | 957 | 0.000 |
Why?
|
Digoxin | 1 | 1981 | 41 | 0.000 |
Why?
|
Lumbosacral Region | 1 | 1980 | 33 | 0.000 |
Why?
|
Injections | 1 | 1980 | 153 | 0.000 |
Why?
|
Neurologic Manifestations | 1 | 1979 | 6 | 0.000 |
Why?
|
Anesthesia, General | 1 | 1980 | 111 | 0.000 |
Why?
|
Ligation | 1 | 1979 | 132 | 0.000 |
Why?
|
Brachial Artery | 1 | 1978 | 38 | 0.000 |
Why?
|
Arteries | 1 | 1979 | 221 | 0.000 |
Why?
|
Vascular Diseases | 1 | 1978 | 163 | 0.000 |
Why?
|
Electric Conductivity | 1 | 1977 | 89 | 0.000 |
Why?
|
Skin | 1 | 1980 | 506 | 0.000 |
Why?
|
Blood Proteins | 1 | 1977 | 116 | 0.000 |
Why?
|
Cold Temperature | 1 | 1975 | 80 | 0.000 |
Why?
|
Sheep | 1 | 1976 | 208 | 0.000 |
Why?
|
Embolism, Air | 1 | 1975 | 25 | 0.000 |
Why?
|
Blood Volume | 1 | 1975 | 80 | 0.000 |
Why?
|
Pressure | 1 | 1975 | 129 | 0.000 |
Why?
|
Orthomyxoviridae | 1 | 1974 | 50 | 0.000 |
Why?
|
Hemoglobinometry | 1 | 1974 | 4 | 0.000 |
Why?
|
Partial Pressure | 1 | 1974 | 28 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1974 | 391 | 0.000 |
Why?
|
Nylons | 1 | 1974 | 12 | 0.000 |
Why?
|
Telemetry | 1 | 1973 | 26 | 0.000 |
Why?
|
Air | 1 | 1973 | 26 | 0.000 |
Why?
|
Central Venous Pressure | 1 | 1973 | 25 | 0.000 |
Why?
|
Lactates | 1 | 1973 | 93 | 0.000 |
Why?
|
Polymers | 1 | 1974 | 106 | 0.000 |
Why?
|
Potassium | 1 | 1974 | 279 | 0.000 |
Why?
|
Feedback | 1 | 1974 | 162 | 0.000 |
Why?
|
Sodium | 1 | 1974 | 291 | 0.000 |
Why?
|
Chick Embryo | 1 | 1973 | 132 | 0.000 |
Why?
|
Blood Platelets | 1 | 1975 | 333 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1975 | 1683 | 0.000 |
Why?
|
Collateral Circulation | 1 | 1970 | 45 | 0.000 |
Why?
|
Trypsin Inhibitors | 1 | 1970 | 5 | 0.000 |
Why?
|
Alpha-Globulins | 1 | 1970 | 10 | 0.000 |
Why?
|
Brachiocephalic Veins | 1 | 1970 | 11 | 0.000 |
Why?
|
Carotid Artery Injuries | 1 | 1970 | 39 | 0.000 |
Why?
|
Isoproterenol | 1 | 1969 | 105 | 0.000 |
Why?
|
Tricuspid Valve | 1 | 1969 | 59 | 0.000 |
Why?
|
Glucagon | 1 | 1969 | 185 | 0.000 |
Why?
|
Surgical Wound Infection | 1 | 1970 | 261 | 0.000 |
Why?
|
Lymphocytes | 1 | 1970 | 402 | 0.000 |
Why?
|
Pneumothorax | 1 | 1968 | 80 | 0.000 |
Why?
|
Tracheotomy | 1 | 1967 | 35 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1979 | 1862 | 0.000 |
Why?
|
Wounds and Injuries | 1 | 1970 | 364 | 0.000 |
Why?
|
Vascular Surgical Procedures | 1 | 1970 | 565 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 1969 | 1804 | 0.000 |
Why?
|